
Results
170
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
170 companies
Eli Lilly
Market Cap: US$949.7b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$1,065.00
7D
7.8%
1Y
49.2%
Johnson & Johnson
Market Cap: US$564.1b
Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.
JNJ
US$234.34
7D
2.4%
1Y
53.2%
AbbVie
Market Cap: US$381.1b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$215.70
7D
3.0%
1Y
17.7%
Merck
Market Cap: US$302.3b
Operates as a healthcare company worldwide.
MRK
US$122.41
7D
8.8%
1Y
57.8%
AstraZeneca
Market Cap: UK£215.8b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£139.16
7D
1.5%
1Y
33.3%
Amgen
Market Cap: US$183.1b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$339.30
7D
4.6%
1Y
24.9%
Gilead Sciences
Market Cap: US$166.8b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$134.36
7D
3.6%
1Y
25.1%
Thermo Fisher Scientific
Market Cap: US$166.6b
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
TMO
US$448.28
7D
1.4%
1Y
13.9%
Danaher
Market Cap: US$121.7b
Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
DHR
US$172.00
7D
5.0%
1Y
-6.8%
Vertex Pharmaceuticals
Market Cap: US$110.3b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTX
US$434.52
7D
-0.5%
1Y
-0.3%
Chugai Pharmaceutical
Market Cap: JP¥13.4t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥8,117.00
7D
2.9%
1Y
7.3%
Jiangsu Hengrui PharmaceuticalsLtd
Market Cap: CN¥328.3b
A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.
600276
CN¥49.43
7D
-5.7%
1Y
-7.3%
Galderma Group
Market Cap: CHF 37.2b
Operates as a dermatology company worldwide.
GALD
CHF 158.65
7D
3.5%
1Y
51.8%
WuXi AppTec
Market Cap: CN¥311.2b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥102.55
7D
0.5%
1Y
66.3%
Haleon
Market Cap: UK£30.5b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£3.44
7D
2.0%
1Y
-16.5%
Teva Pharmaceutical Industries
Market Cap: US$39.7b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$34.07
7D
0.1%
1Y
100.9%
Otsuka Holdings
Market Cap: JP¥6.1t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥11,525.00
7D
3.1%
1Y
68.2%
Sandoz Group
Market Cap: CHF 27.9b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 64.44
7D
-0.9%
1Y
57.4%
CSL
Market Cap: AU$47.8b
Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
CSL
AU$98.47
7D
2.3%
1Y
-60.1%
Waters
Market Cap: US$33.6b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$342.37
7D
3.1%
1Y
-1.2%
Daiichi Sankyo Company
Market Cap: JP¥4.9t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥2,700.50
7D
3.1%
1Y
-29.2%
Natera
Market Cap: US$29.1b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$203.19
7D
5.5%
1Y
32.5%
IQVIA Holdings
Market Cap: US$28.0b
Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
IQV
US$167.90
7D
-2.8%
1Y
22.6%
Hansoh Pharmaceutical Group
Market Cap: HK$204.4b
An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
3692
HK$33.72
7D
-4.1%
1Y
31.5%
Illumina
Market Cap: US$21.8b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$144.41
7D
2.0%
1Y
79.7%
Innovent Biologics
Market Cap: HK$140.5b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$80.95
7D
-1.3%
1Y
38.1%
WuXi Biologics (Cayman)
Market Cap: HK$135.4b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil.
2269
HK$32.72
7D
-2.9%
1Y
37.2%
Shionogi
Market Cap: JP¥2.6t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥3,029.00
7D
-0.7%
1Y
28.4%
Ipsen
Market Cap: €13.2b
A biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide.
IPN
€162.70
7D
5.0%
1Y
58.4%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$110.6b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$474.20
7D
8.6%
1Y
48.9%
Akeso
Market Cap: HK$107.4b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$116.60
7D
-3.0%
1Y
40.2%
ALTEOGEN
Market Cap: ₩19.5t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩364,500.00
7D
2.0%
1Y
10.0%
Medpace Holdings
Market Cap: US$12.4b
Provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
MEDP
US$432.80
7D
2.9%
1Y
46.8%
Recordati Industria Chimica e Farmaceutica
Market Cap: €10.4b
Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
REC
€51.55
7D
1.5%
1Y
-0.2%
Orion Oyj
Market Cap: €10.0b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€72.50
7D
5.1%
1Y
24.4%
Zhangzhou Pientzehuang Pharmaceutical
Market Cap: CN¥74.8b
Manufactures and distributes pharmaceuticals and cosmetics in China and internationally.
600436
CN¥123.96
7D
-4.9%
1Y
-39.2%